It has been a mixed year for Surgery Partners, Inc. insiders: $305,000 bought by one person and $1.3 million sold by six, so more selling than buying overall.
The largest purchase came from DeLuca Teresa (Director), about $161,000.
On the institutional side, 187 funds reported holding SGRY at the end of Q2 2026, and more funds bought than sold. Last full quarter: net buying by insiders. Insiders bought in 1 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Aug 20, 2026 | DeLuca Teresa | Director | Buy | 11,250 | $14.33 | $161K | SEC |
| Aug 19, 2026 | DeLuca Teresa | Director | Buy | 10,000 | $14.35 | $144K | SEC |
| Mar 16, 2026 | Burkhalter Danielle | Executive Officer | Sell | 3,469 | $12.83 | $45K | SEC |
| Mar 16, 2026 | Brittenham Marissa | Executive Officer | Sell | 3,657 | $12.54 | $46K | SEC |
| Mar 16, 2026 | Doherty David T | CFO | Sell | 8,867 | $12.50 | $111K | SEC |
| Mar 16, 2026 | Evans Jason Eric | CEO | Sell | 20,400 | $12.47 | $254K | SEC |
| Mar 16, 2026 | Baldock Jennifer | Executive Officer | Sell | 5,798 | $13.17 | $76K | SEC |
| Mar 9, 2026 | Evans Jason Eric | CEO | Sell | 11,462 | $13.79 | $158K | SEC |
| Mar 9, 2026 | Doherty David T | CFO | Sell | 14,574 | $13.84 | $202K | SEC |
| Mar 9, 2026 | Baldock Jennifer | Executive Officer | Sell | 10,082 | $13.70 | $138K | SEC |
| Mar 9, 2026 | Burkhalter Danielle | Executive Officer | Sell | 7,736 | $13.60 | $105K | SEC |
| Mar 9, 2026 | Webb William Trenton | President | Sell | 272 | $13.93 | $4K | SEC |
| Mar 9, 2026 | Webb William Trenton | President | Sell | 1,794 | $13.86 | $25K | SEC |
| Mar 9, 2026 | Brittenham Marissa | Executive Officer | Sell | 8,785 | $13.70 | $120K | SEC |
| Sep 8, 2025 | Bane Harrison R. | President | Sell | 5,726 | $22.48 | $129K | SEC |
In the last 12 months Surgery Partners, Inc. insiders made open-market purchases worth about $305,000 and sales worth about $1.3 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in SGRY was filed on 2026-08-20.
187 investment managers reported holding SGRY in SEC Form 13F filings for Q2 2026.
No congressional trades in SGRY were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).